|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 38/17 | |||
| C12P 21/08 | |||
| A61K 39/00 | |||
| C07K 16/18 |
| (11) | Number of the document | 2450056 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11175183.0 |
| Date of filing the European patent application | 2006-07-19 | |
| (97) | Date of publication of the European application | 2012-05-09 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 185907 | 2005-07-19 | US | |
| PCT/US2005/0281 | 2005-08-09 | WO |
| (72) |
Schenk, Dale B., US
Masliah, Eliezer, US
Buttini, Manuel J., US
Chilcote, Tamie J., US
Rockenstein, Edward, US
Games, Dora Kate, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
Prothena Biosciences Limited, Adelphi Plaza Upper George`s Street D n Laoghaire, Co. Dublin, A96 T927, IE |
| (54) | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| Prevention and treatment of synucleinopathic and amyloidogenic disease |